Financial Highlights: Period Jan – Sep 2009

Sales grew by 23% to Rs. 3644 million. The profit before taxes fell by 10.3% to Rs. 676 million. Earnings after taxes fell by 9.9% to Rs. 467 million. An amount of Rs. 89.1 million was added to the fixed assets during Jan-Sep 2009. The Company has investments in Bank Deposits and Liquid funds of Rs. 3044 million.

The core of the Pharmaceuticals business comprises of formulations used in area of cardiovascular, metabolic diseases and vitamins. Sales in the Pharmaceuticals business sector grew by 13.3% from Rs. 2399.98 million in Jan to Sep 2008 to Rs. 2719.27 million in Jan to Sep 2009. The Pharmaceuticals sector accounts for 74.6 % of the Company’s total sales.

The Chemical business comprises of Bulk Pharma Compounds and Specialty Pigments. Sales in the Chemical business grew by 64.6% from Rs. 561.64 million in Jan to Sep 2008 to Rs. 924.73 million in Jan to Sep 2009. The chemical business sector accounts for 25.4% of the Company’s total sales.